[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]
- PMID: 16856516
[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]
Abstract
Behavioral and psychological symptoms of dementia (BPSD) includes anxiety, depression, hallucination, delusion, aggression, irritability, agitation and wandering. BPSD often causes a deterioration of activity of daily living (ADL) and worsens caregiver burden. Trazodone, an atypical antidepressant, is used for the treatment of BPSD, but the effectiveness is controversial. In this study, we retrospectively analyzed the medical records of the 13 AD patients who were rated as having the aggression and negativism in caregiving situation and were treated by trazodone. The BPSD of the per-treatment stage of the patients was assessed with Neoropsychiatric Inventory(NPI). Improvement of BPSD after trazodone was observed in 9 patients, and the aggression and negativism in caregiving situations were improved in 6 patient. Trazodone may be effect for the treatment of a certain type of BPSD such as aggression and negativism in caregiving situations. Prospective studies of this issue are recommended in AD patient.
Similar articles
-
Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.Dement Geriatr Cogn Disord. 2007;23(4):219-24. doi: 10.1159/000099472. Epub 2007 Feb 9. Dement Geriatr Cogn Disord. 2007. PMID: 17299264
-
Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.Psychiatry Clin Neurosci. 2005 Jun;59(3):274-9. doi: 10.1111/j.1440-1819.2005.01371.x. Psychiatry Clin Neurosci. 2005. PMID: 15896220 Clinical Trial.
-
Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):308-11. doi: 10.1016/j.pnpbp.2008.12.008. Epub 2008 Dec 24. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19138715
-
[Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].Fortschr Neurol Psychiatr. 2002 Feb;70(2):78-83. doi: 10.1055/s-2002-19920. Fortschr Neurol Psychiatr. 2002. PMID: 11823923 Review. German.
-
Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.J Clin Psychiatry. 2001;62 Suppl 21:19-22. J Clin Psychiatry. 2001. PMID: 11584983 Review.
Cited by
-
Alternatives to atypical antipsychotics for the management of dementia-related agitation.Drugs Aging. 2008;25(5):381-98. doi: 10.2165/00002512-200825050-00003. Drugs Aging. 2008. PMID: 18447403 Review.
-
Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.Neuropsychiatr Dis Treat. 2023 Dec 21;19:2817-2831. doi: 10.2147/NDT.S434130. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38155994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical